COSMO Pharmaceuticals Valuation
| COPN Stock | CHF 63.20 0.40 0.64% |
At this time, the firm appears to be overvalued. COSMO Pharmaceuticals shows a prevailing Real Value of ₣49.3 per share. The current price of the firm is ₣63.2. Our model approximates the value of COSMO Pharmaceuticals from analyzing the firm fundamentals such as return on equity of 0.0841, and Profit Margin of 0.45 % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that COSMO Pharmaceuticals' price fluctuation is very steady at this time. Calculation of the real value of COSMO Pharmaceuticals is based on 3 months time horizon. Increasing COSMO Pharmaceuticals' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the COSMO stock is determined by what a typical buyer is willing to pay for full or partial control of COSMO Pharmaceuticals SA. Since COSMO Pharmaceuticals is currently traded on the exchange, buyers and sellers on that exchange determine the market value of COSMO Stock. However, COSMO Pharmaceuticals' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 63.2 | Real 49.3 | Hype 63.2 |
The intrinsic value of COSMO Pharmaceuticals' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence COSMO Pharmaceuticals' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of COSMO Pharmaceuticals SA helps investors to forecast how COSMO stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of COSMO Pharmaceuticals more accurately as focusing exclusively on COSMO Pharmaceuticals' fundamentals will not take into account other important factors: COSMO Pharmaceuticals Total Value Analysis
COSMO Pharmaceuticals SA is currently anticipated to have takeover price of 960.99 M with market capitalization of 1.12 B, debt of 169.03 M, and cash on hands of 217.97 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the COSMO Pharmaceuticals fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
960.99 M | 1.12 B | 169.03 M | 217.97 M |
COSMO Pharmaceuticals Investor Information
About 47.0% of the company shares are held by company insiders. The book value of COSMO Pharmaceuticals was currently reported as 28.23. The company last dividend was issued on the 1st of June 2022. Based on the key indicators related to COSMO Pharmaceuticals' liquidity, profitability, solvency, and operating efficiency, COSMO Pharmaceuticals SA is not in a good financial situation at the moment. It has a very high risk of going through financial straits in December.COSMO Pharmaceuticals Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. COSMO Pharmaceuticals has an asset utilization ratio of 8.08 percent. This indicates that the Company is making ₣0.0808 for each dollar of assets. An increasing asset utilization means that COSMO Pharmaceuticals SA is more efficient with each dollar of assets it utilizes for everyday operations.COSMO Pharmaceuticals Ownership Allocation
COSMO Pharmaceuticals holds a total of 16.38 Million outstanding shares. COSMO Pharmaceuticals SA retains noticeable amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.COSMO Pharmaceuticals Profitability Analysis
The company reported the revenue of 65.07 M. Net Income was 21.67 M with profit before overhead, payroll, taxes, and interest of 32.1 M.About COSMO Pharmaceuticals Valuation
Our relative valuation model uses a comparative analysis of COSMO Pharmaceuticals. We calculate exposure to COSMO Pharmaceuticals's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of COSMO Pharmaceuticals's related companies.Cosmo Pharmaceuticals N.V., a specialty pharmaceutical company, develops, manufactures, and distributes products for gastroenterology and endoscopy worldwide. Cosmo Pharmaceuticals N.V. was founded in 1997 and is headquartered in Dublin, Ireland. COSMO PHARM operates under Drug Manufacturers - Major classification in Switzerland and is traded on Switzerland Exchange. It employs 306 people.
8 Steps to conduct COSMO Pharmaceuticals' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates COSMO Pharmaceuticals' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct COSMO Pharmaceuticals' valuation analysis, follow these 8 steps:- Gather financial information: Obtain COSMO Pharmaceuticals' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine COSMO Pharmaceuticals' revenue streams: Identify COSMO Pharmaceuticals' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research COSMO Pharmaceuticals' industry and market trends, including the size of the market, growth rate, and competition.
- Establish COSMO Pharmaceuticals' growth potential: Evaluate COSMO Pharmaceuticals' management, business model, and growth potential.
- Determine COSMO Pharmaceuticals' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate COSMO Pharmaceuticals' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for COSMO Stock Analysis
When running COSMO Pharmaceuticals' price analysis, check to measure COSMO Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy COSMO Pharmaceuticals is operating at the current time. Most of COSMO Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of COSMO Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move COSMO Pharmaceuticals' price. Additionally, you may evaluate how the addition of COSMO Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.